Choudhury, A. D., Zhong, C., Xie, W., Bonavolonta, J., Leisner, C., Thapa, B., Wei, X. X., Ravi, P., Roberts, D. A., Zaemes, J. P., King, M. T. (2026). Comeback from long-course ADT with relugolix (rel) and darolutamide (daro) in hormone-sensitive prostate cancer (PC) (CLEARED).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.5083